Financial Times Examines Pharma's Growing Interest in India
January 27, 2011
"International pharmaceutical companies once looked with frustration at Indian drug makers, which were notorious for churning out low-cost, copycat versions of patented drugs and selling them to developing countries. More recently, they have been looking at Indias fast growing pharmaceutical industry in a different light -- as an increasingly integral part of the global supply chain in an environment of intensifying pressure on prices," the Financial Times writes. The article, which documents the rise of foreign-owned companies in India's domestic drug market, notes, "Recent takeovers have raised concerns among some policymakers that foreign ownership may lead to sharply higher domestic drug prices, potentially a big problem in a country where 80 per cent of total healthcare costs are shouldered privately" (Kazmin, 1/26).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)